metformin vs glp 1 Comparing Glucagon‐like peptide‐1 receptor agonists versus in drug‐naive patients: A nationwide cohort study Full article: Will delayed release

Description

These check-ins include reviewing weight loss progress, tracking any side effects, and addressing any concerns that may arise

2 1

Glucagon-like peptide-1 (GLP-1) receptor agonists semaglutide and tirzepatide, which have been approved by the US Food and Drug Administration for the treatment of obesity and diabetes, may also reduce symptoms in patients with obstructive sleep apnea (OSA)

GLP-1 RAs mimic our bodys natural GLP-1

Most individuals regain significant weight once these medications are stopped. Of the participants, 21 were using tirzepatide (Mounjaro and Zepbound), and nine were using semaglutide